Trevi Therapeutics to Participate in Upcoming April Events [Yahoo! Finance]
Trevi Therapeutics, Inc. (TRVI)
Company Research
Source: Yahoo! Finance
investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC), today announced that senior management will attend and participate in the following events in April. rd Annual Needham Virtual Healthcare Conference April 8-11, 2024 Fireside Chat: Monday, April 8 at 1:30 PM ET Trevi Representatives: Jennifer Good, President and CEO, Lisa Delfini , CFO, and Farrell Simon, CCO A live webcast of the 23 rd Annual Needham Virtual Healthcare Conference fireside chat will be accessible from the 'Investors & News' section on the Company's website at www.TreviTherapeutics.com . An archived replay of the webcast will also be available for 30 days on the Company's website following the event. European Pulmonary Fibrosis Foundation Patient Summit April 26-28, 2024 Barcelona, Spain Roundtable Discussion: Sunday, April 28 at 11:15 AM CET Title: Roundtable on clinical trials: Exploring Oppo
Show less
Read more
Impact Snapshot
Event Time:
TRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRVI alerts
High impacting Trevi Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TRVI
News
- Trevi Therapeutics, Inc. (NASDAQ: TRVI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.MarketBeat
- Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference [Yahoo! Finance]Yahoo! Finance
- Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International ConferencePR Newswire
- Trevi Therapeutics to Participate in Upcoming April EventsPR Newswire
- Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight [Yahoo! Finance]Yahoo! Finance
TRVI
Earnings
- 3/20/24 - Beat
TRVI
Sec Filings
- 4/29/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- TRVI's page on the SEC website